Chondroitin sulfate C lithium

硫酸软骨素C锂

Report date: 2022/03/09 14:48:02

Base Information

Drug NameChondroitin sulfate C lithium
Drug Alias Name硫酸软骨素锂鲨鱼硫酸软骨素锂鲨鱼软骨素锂
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTaishan Medical University Affiliated Hospital
China Registration ClassN/A

Develop Information

Active CompaniesTaishan Medical University Affiliated Hospital
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A